Generic and Brand-Name Drug Makers Face Off

“Teva Pharmaceuticals, a leading manufacturer of generic drugs, has been aggressively lobbying Congress to scrap provisions in the health care bills it claims would shut it out of the biologic drug market for too long,” Roll Call reports. Lobbyists for the biologics makers have charged, however, that Teva is hypocritical because it is fighting to restrict generic production of its own brand-name product. “Depending on which business hat they are wearing, they are coming up with different scientific standards,” one biologics lobbyist said. “The complaints underscore how bitter the high-stakes battle between generic and brand-name drug companies has become as Congress decides how boldly to restrict entry into the potentially lucrative generic biologic, or biosimilar, market.” Current proposals would give brand-name makers 12 years of exclusivity. Generics makers hope to bring that time down to five to seven years (Roth, 11/18). Go to Source

People who read this also read

• Spiropyran-based optical approaches for mercury ion sensing: Improving sensitivity and selectivity via cooperative ligation interactions using cysteine.
  Authors: Shao N, Gao X, Wang H, Yang R, Chan W Spiropyrans are an attractive starting point in design of optical approaches for metal ions sensing. However, the high background in aqueous solution and non-specific chelation of the spiropyran with heavy metal ions has hindered their application a...
• Paramedic Disabled During Emergency Call-out Receives Compensation, UK
  "I have gone from a strong person, who could do anything, to someone who struggles to pick up a small box from the floor." These are the words of a paramedic, who has been awarded £200,000 for becoming permanently disabled after falling while attending an emergency call. Go to Source...
• Cluster Of ‘critical’ Follow-up Evaluations May Improve The Outlook For Hospitalised Heart Failure Patients
  A new report published in the European Journal of Heart Failure notes mortality rates as high as 10 per cent and rehospitalisation rates of 30 per cent after discharge among heart failure (HF) patients admitted to hospital. This reflects previous studies of hospitalised Medicare patients in the USA ...
• School Classroom Air May Be More Polluted With Ultrafine Particles Than Outdoor Air
  The air in some school classrooms may contain higher levels of extremely small particles of pollutants - easily inhaled deep into the lungs - than polluted outdoor air, scientists in Australia and Germany are reporting in an article in ACS' semi-monthly journal Environmental Science & Technology...
• Waterpipes no safer than cigarettes: study
  If you thought that smoking tobacco through a waterpipe was safer than cigarettes, think again: Compared to cigarette smoking, a waterpipe—also called a hookah or shisha—delivers more deadly carbon monoxide and roughly the same amount of addictive nicotine, according to a new study. “This study ca...